LYEL Dividend History & Analysis | N/A Yield
LYEL has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
As of February 2026, Lyell Immunopharma (LYEL) does not pay a dividend.
Top Dividend Payers in Biotechnology
Top 5 Dividend Yields of Peer-Group
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| QIA | 10,081 M | 5.23% | 5.40% |
| ABBV | 396,513 M | 3.34% | 7.47% |
| GILD | 187,492 M | 2.79% | 7.85% |
| AMGN | 202,420 M | 3.89% | 5.02% |
| HLN | 49,341 M | 1.76% | 2.46% |
Top 5 Dividend Growth Rates of Peer-Group
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| BTX | 1,408 M | 134% | 95.6% |
| HLN | 49,341 M | 30.1% | 100% |
| PHM | 1,508 M | 13.3% | 47.9% |
| AMGN | 202,420 M | 7.84% | 100% |
| BIM | 13,252 M | 9.76% | 96.0% |
Quality Dividend Peers in Biotechnology
AMGN
Amgen
3.89% Yield
3.89% Yield
GILD
Gilead Sciences
2.79% Yield
2.79% Yield
LYEL Dividend History: as of February 2026
No dividends paid yet.LYEL Dividend FAQ
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company develops therapies using various approaches, such as c-Jun overexpression and NR4A3 gene knockout, to endow functional resistance to exhaustion;...What is the Dividend Yield of LYEL?
As of February 2026, LYEL`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 23.07.Does LYEL pay a dividend?
As of February 2026 LYEL does not pay a dividend.How often does LYEL pay dividends?
Over the last 12 months, LYEL has issued dividend payments.LYEL dividend forecast
Based on historical data, the forecasted dividends per share for LYEL for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will LYEL pay dividends in 2026?
The next Ex-Dividend date for Lyell Immunopharma (LYEL) is currently unknown.What is the next Ex-Dividend Date for LYEL?
The next Ex-Dividend date for Lyell Immunopharma (LYEL) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of LYEL?
LYEL's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of LYEL?
LYEL's 5-Year Yield on Cost is -%. If you bought LYEL's shares at 337.80 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of LYEL?
LYEL Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does LYEL have a good Dividend Yield?
LYEL`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of LYEL?
The Dividend Payout Ratio of LYEL is unknown.What is the Dividend Rating of LYEL?
LYEL`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-02-16 02:16